Related Experiment Videos
Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting
L Kotaniemi-Talonen1, P Nieminen, A Anttila
1Mass Screening Registry, Finnish Cancer Registry, Liisankatu 21 B, FI-00170 Helsinki, Finland. laura.kotaniemi-talonen@cancer.fi
British Journal of Cancer
|September 29, 2005
Summary
Primary high-risk human papillomavirus (hrHPV) testing increases cervical cancer detection sensitivity but lowers specificity. Adding cytology triage to hrHPV testing restores specificity to conventional cytology levels.
Area of Science:
- Gynecology
- Oncology
- Public Health
Background:
- The effectiveness of high-risk human papillomavirus (hrHPV) testing in primary cervical cancer screening requires further evaluation.
- Routine implementation of hrHPV testing in screening programs needs assessment for its impact on program effectiveness.
Purpose of the Study:
- To assess the cross-sectional relative validity of routine hrHPV screening compared to conventional cytology in the first year of implementation.
- To determine if primary hrHPV testing enhances the effectiveness of cervical screening programs.
Main Methods:
- A randomized evaluation design was employed, allocating women to either primary hrHPV screening (n=7060) or conventional cytological screening (n=7089).
- In the hrHPV arm, positive hrHPV results were triaged with cytology to determine the need for colposcopy referral.
Main Results:
- The hrHPV screening arm resulted in more colposcopy referrals (relative risk 1.51) compared to the conventional arm.
- Primary hrHPV testing showed lower specificity (91.5-92.1%) than conventional cytology (99.2-99.6%).
- Cytology triage following a positive hrHPV test improved specificity (98.7-99.3%) to levels comparable with conventional cytology.
Conclusions:
- Primary hrHPV testing offers increased sensitivity for detecting cervical lesions but sacrifices specificity.
- Implementing cytology triage after hrHPV testing significantly enhances specificity, making it a viable option for primary cervical screening.